Search research articles
Contact Us
Filters
Showing results (111-120 of 384) with videos related to
Page
of 39
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
January 15, 2000
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood
B Kaiser, W Jeske, J M Walenga, et al.
Thrombosis Research
|
May 15, 1993
Modulation of endothelial and platelet function by a polydeoxyribonucleotide derived drug "defibrotide". A dual mechanism in the control of vascular pathology
P Bacher, G Kindel, J M Walenga, et al.
Thrombosis Research
|
February 15, 1993
Molecular weight and biochemical profile of a chemically modified heparin derivative, Suleparoide
D D Callas, A Ahsan, O Iqbal, et al.
Investigative Radiology
|
May 1, 1984
Antiplatelet action of intravascular contrast media. Implications in diagnostic procedures
Z Parvez, R Moncada, J Fareed, et al.
Investigative Radiology
|
May 1, 1983
Effects of nonionic contrast media (CM) on the components of coagulation and complement systems
Z Parvez, R Moncada, J Fareed, et al.
Acta Radiologica: Diagnosis
|
January 1, 1982
Ionic and non-ionic contrast media interaction with anticoagulant drugs
Z Parvez, R Moncada, H L Messmore, et al.
Hematology/Oncology Clinics of North America
|
December 1, 1992
Drug-induced alterations of hemostasis and fibrinolysis
J Fareed, D Hoppenstedt, R L Bick, et al.
Thrombosis Research
|
July 18, 2001
Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates
D A Hoppensteadt, J Fareed, P Raake, et al.
Thrombosis Research
|
June 1, 1995
Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model
K Fu, R Izquierdo, J M Walenga, et al.
Thrombosis Research
|
May 1, 1996
Flow cytometric evaluation of the effect of various thrombin inhibitors on platelet activation in whole blood
B Kaiser, M Koza, J M Walenga, et al.
Page
of 39
Search research articles
Search
Showing results (111-120 of 384) with videos related to
Sort By:
Page
of 39
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
January 15, 2000
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood
B Kaiser, W Jeske, J M Walenga, et al.
Thrombosis Research
|
May 15, 1993
Modulation of endothelial and platelet function by a polydeoxyribonucleotide derived drug "defibrotide". A dual mechanism in the control of vascular pathology
P Bacher, G Kindel, J M Walenga, et al.
Thrombosis Research
|
February 15, 1993
Molecular weight and biochemical profile of a chemically modified heparin derivative, Suleparoide
D D Callas, A Ahsan, O Iqbal, et al.
Investigative Radiology
|
May 1, 1984
Antiplatelet action of intravascular contrast media. Implications in diagnostic procedures
Z Parvez, R Moncada, J Fareed, et al.
Investigative Radiology
|
May 1, 1983
Effects of nonionic contrast media (CM) on the components of coagulation and complement systems
Z Parvez, R Moncada, J Fareed, et al.
Acta Radiologica: Diagnosis
|
January 1, 1982
Ionic and non-ionic contrast media interaction with anticoagulant drugs
Z Parvez, R Moncada, H L Messmore, et al.
Hematology/Oncology Clinics of North America
|
December 1, 1992
Drug-induced alterations of hemostasis and fibrinolysis
J Fareed, D Hoppenstedt, R L Bick, et al.
Thrombosis Research
|
July 18, 2001
Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates
D A Hoppensteadt, J Fareed, P Raake, et al.
Thrombosis Research
|
June 1, 1995
Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model
K Fu, R Izquierdo, J M Walenga, et al.
Thrombosis Research
|
May 1, 1996
Flow cytometric evaluation of the effect of various thrombin inhibitors on platelet activation in whole blood
B Kaiser, M Koza, J M Walenga, et al.
Page
of 39